TGFB1 and craniopharyngioma: Further efforts to improve treatment outcomes in patients with craniopharyngiomas should be made by the pattern of multidisciplinary cooperation (49), and our findings of the upregulation of TGF-β1 in the hypothalamic involvement and tumor progression may provide a clue for the molecular pathogenesis of aggressive biological behavior and poor prognosis of ACPs.